# iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF is a ETF series of iShares Trust (series S000009417). Net assets $1.0B as of 2026-03-31. Index fund.

## Profile

- Series ID: S000009417
- Registrant: iShares Trust
- LEI: 549300K3OFF3L3ODU217
- Net assets: $1.0B
- Total assets: $1.0B
- As of: 2026-03-31
- Type: ETF, Index

## Advisers

- [BlackRock Fund Advisors (Advisor)](https://search.stillhousedata.com/firm/105247)

## Top holdings (59 reported)

_Showing 15 of 59 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [JOHNSON & JOHNSON](https://search.stillhousedata.com/security/478160104) | — | $230.4M | 2302.75% |
| [ELI LILLY AND COMPANY](https://search.stillhousedata.com/security/532457108) | — | $210.7M | 2105.77% |
| [MERCK & CO., INC.](https://search.stillhousedata.com/security/58933Y105) | — | $47.4M | 473.89% |
| [PFIZER INC.](https://search.stillhousedata.com/security/717081103) | — | $47.1M | 470.90% |
| [ROYALTY PHARMA PLC](https://search.stillhousedata.com/security/G7709Q104) | — | $47.1M | 470.37% |
| [BRISTOL-MYERS SQUIBB COMPANY](https://search.stillhousedata.com/security/110122108) | — | $46.3M | 462.93% |
| [ZOETIS INC.](https://search.stillhousedata.com/security/98978V103) | — | $45.2M | 451.78% |
| [BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares](https://search.stillhousedata.com/security/066922519) | — | $43.6M | 435.55% |
| [VIATRIS INC.](https://search.stillhousedata.com/security/92556V106) | — | $43.5M | 434.64% |
| [ELANCO ANIMAL HEALTH INCORPORATED](https://search.stillhousedata.com/security/28414H103) | — | $33.2M | 332.12% |
| [JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY](https://search.stillhousedata.com/security/G50871105) | — | $32.1M | 320.88% |
| [AXSOME THERAPEUTICS, INC.](https://search.stillhousedata.com/security/05464T104) | — | $20.0M | 199.93% |
| [Terns Pharmaceuticals Inc](https://search.stillhousedata.com/security/880881107) | — | $12.7M | 126.68% |
| [LIGAND PHARMACEUTICALS INCORPORATED](https://search.stillhousedata.com/security/53220K504) | — | $11.0M | 109.76% |
| [INDIVIOR PHARMACEUTICALS, INC.](https://search.stillhousedata.com/security/45579U109) | — | $10.6M | 106.30% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-03-31 | $1.0B |
| 2025-12-31 | $847.7M |
| 2025-09-30 | $580.8M |
| 2025-06-30 | $550.5M |
| 2025-03-31 | $617.3M |
| 2024-12-31 | $610.6M |
| 2024-09-30 | $660.1M |
| 2024-06-30 | $683.5M |

## More

- [Registrant: iShares Trust](https://search.stillhousedata.com/registrant/1100663)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000009417.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.